GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MedAvail Holdings Inc (STU:73M) » Definitions » YoY EBITDA Growth

MedAvail Holdings (STU:73M) YoY EBITDA Growth : 17.10% (As of Jun. 2023)


View and export this data going back to 2020. Start your Free Trial

What is MedAvail Holdings YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. MedAvail Holdings's YoY EBITDA Growth for the quarter that ended in Jun. 2023 was 17.10%.

MedAvail Holdings's EBITDA per Share for the three months ended in Jun. 2023 was €-2.53.


MedAvail Holdings YoY EBITDA Growth Historical Data

The historical data trend for MedAvail Holdings's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedAvail Holdings YoY EBITDA Growth Chart

MedAvail Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22
YoY EBITDA Growth
- -529.11 67.85 45.62

MedAvail Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 75.71 54.04 65.60 -0.77 17.10

MedAvail Holdings YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

MedAvail Holdings's YoY EBITDA Growth for the fiscal year that ended in Dec. 2022 is calculated as:

YoY EBITDA Growth (A: Dec. 2022 )
=(EBITDA per Share (A: Dec. 2022 )-EBITDA per Share (A: Dec. 2021 ))/ | EBITDA per Share (A: Dec. 2021 ) |
=(-29.959--55.089)/ | -55.089 |
=45.62 %

MedAvail Holdings's YoY EBITDA Growth for the quarter that ended in Jun. 2023 is calculated as:

YoY EBITDA Growth (Q: Jun. 2023 )
=(EBITDA per Share (Q: Jun. 2023 )-EBITDA per Share (Q: Jun. 2022 )) / | EBITDA per Share (Q: Jun. 2022 )) |
=(-2.525--3.046)/ | -3.046 |
=17.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedAvail Holdings YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of MedAvail Holdings's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


MedAvail Holdings (STU:73M) Business Description

Traded in Other Exchanges
Address
4720 East Cotton Gin Loop, Suite 220, Phoenix, AZ, USA, 85040
MedAvail Holdings Inc is a telehealth-enabled pharmacy technology company. It operates in two segments: Retail Pharmacy Services and Pharmacy Technology. It generates the majority of revenue from the Retail Pharmacy Services segment, which is into operating SpotRx, a full-service retail pharmacy utilizing MedAvail's automated pharmacy technology, primarily servicing Medicare patients in the United States. The Pharmacy Technology segment develops and commercializes the MedCenter for direct sale or lease to third-party customers.

MedAvail Holdings (STU:73M) Headlines

No Headlines